Numbers released last month by a team of doctors in New York are fairly staggering: Over the next 20 years, testosterone deficiency will be involved in the development of more than a million new cases of cardiovascular disease and another million cases of diabetes, and also more than 600,000 cases of osteoporosis related fractures.
Dr. Daniel J. Moskovic of the Memorial Sloan-Kettering Cancer Center along with colleagues collected and analyzed data from six national databases and several large cross-sectional studies to reach their conclusions.
Perhaps what is more eye-opening is the estimated healthcare costs Moskovic attributed to low testosterone. According to his research, in the first year, low T was said to be responsible for $8.4 billion dollars in healthcare costs. For the entire 20 year period, between $1900 billion and $525 billion in inflation-adjusted expenditures could be tied to low testosterone.